Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • cystron
    Junior Member
    • Jan 2011
    • 7

    #1

    Where do NGS projects most often Fail?

    When thinking about a new project, where do you see the most failures?
    1. DNA/RNA extraction
    2. Library Prep
    3. Sequencing Run
    4. Alignment / Assembly
    5. Secondary/Tertiary analysis and BioInformatics

    At what point do you finally feel like a project is "safe"?
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    I am not sure if this question has a generally applicable answer. Projects can fail at any step mentioned in your list. A project can never be "safe" (to borrow your phrase) until the data is analyzed and the paper written :-)

    Comment

    • gringer
      David Eccles (gringer)
      • May 2011
      • 845

      #3
      Experimental design: not choosing appropriate controls, too few biological replicates, or doing sequencing on the wrong cell population (e.g. whole-blood RNASeq for an obesity study).

      Comment

      • Genetic Librarian
        Member
        • May 2017
        • 31

        #4
        Originally posted by gringer View Post
        Experimental design: not choosing appropriate controls, too few biological replicates, or doing sequencing on the wrong cell population (e.g. whole-blood RNASeq for an obesity study).
        This!

        Biggest mistake is too few replicates. Individual samples can drop out for a variety of reasons, so easily your glorious n=3 study has treatments with only 2 replicates in them. And you can not easily repeat the missing samples without having a potential batch effect confounder.

        Also, from my experience as a core lab head, usually it is "**** in, **** out", meaning most library preps / sequencing runs fail because input material was not ideal (but customer wanted to try anyway after being contacted following QC).

        Comment

        • kwaraska
          Senior Member
          • Nov 2008
          • 131

          #5
          To second what another poster said.....there is no safe place until you have your data analyzed but the most common problem is garbage in,garbage out. In the core lab I was in, we had similar issues where a customer would insist we use their sub-optimal ample, and the data would commonly be garbage.

          It is worth checking all samples on a Bioanalyzer or Tape Station type instrument to really look at what you are dealing with. The most common issue would be someone using a nanodrop to get a concentration, but upon TS we would find it was less than 50% of what they reported

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
            by SEQadmin2



            CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

            Despite this, “CRISPR helped turn genome editing from a specialized technique into
            ...
            07-31-2026, 11:01 AM
          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            07-20-2026, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 07-31-2026, 02:55 AM
          0 responses
          14 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-24-2026, 12:17 PM
          0 responses
          15 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-23-2026, 11:41 AM
          0 responses
          13 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-20-2026, 11:10 AM
          0 responses
          24 views
          0 reactions
          Last Post SEQadmin2  
          Working...